Cargando…

Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK

INTRODUCTION: This analysis compared healthcare resource use (HCRU) and costs associated with incident organ damage in a cohort of adult patients with systemic lupus erythematosus (SLE). METHODS: Incident SLE cases were identified (Clinical Practice Research Datalink [CPRD] and Hospital Episode Stat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stirnadel-Farrant, Heide A., Golam, Sarowar M., Naisbett-Groet, Barbara, Gibson, Danny, Langham, Julia, Langham, Sue, Samnaliev, Mihail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468441/ https://www.ncbi.nlm.nih.gov/pubmed/37400683 http://dx.doi.org/10.1007/s40744-023-00567-9

Ejemplares similares

Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Disease severity, flares and treatment patterns in adults with systemic lupus erythematosus in the UK: a real-world observational retrospective cohort analysis
por: Langham, Julia, et al.
Publicado: (2021)

Health-care utilization and costs in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort analysis
por: Samnaliev, Mihail, et al.
Publicado: (2021)

Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis
por: Yazdany, Jinoos, et al.
Publicado: (2020)

The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis
por: Pego-Reigosa, José María, et al.
Publicado: (2020)

Impact of SARS-CoV-2 infection on patients with systemic lupus erythematosus in England prior to vaccination: a retrospective observational cohort study
por: Rabe, Adrian Paul J, et al.
Publicado: (2023)

Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
por: Kerkhof, Marjan, et al.
Publicado: (2018)

Pseudomonas luteola Bacteremia in Newly Diagnosed Systemic Lupus Erythematosus
por: Barry, Mazin
Publicado: (2021)

Periodontal Disease in Patients with Newly Diagnosed Systemic Lupus Erythematosus
por: Sahebari, Maryam, et al.
Publicado: (2023)

Changing use of antidiabetic drugs in the UK: trends in prescribing 2000–2017
por: Wilkinson, Samantha, et al.
Publicado: (2018)

Malignancies among newly diagnosed systemic lupus erythematosus patients and their survival
por: Kariniemi, Simo, et al.
Publicado: (2022)

Major Infections of Newly Diagnosed Childhood-Onset Systemic Lupus Erythematosus
por: Bao, Shengfang, et al.
Publicado: (2023)

Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study
por: Wang, Haiting, et al.
Publicado: (2022)

Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review
por: Langham, Sue, et al.
Publicado: (2011)

Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis
por: Bell, Christopher F, et al.
Publicado: (2023)

Retinopathy in newly-diagnosed systemic lupus erythematosus: should we screen for ocular involvement?
por: Bashiri, Hamidreza, et al.
Publicado: (2021)

Altered Profile of Fecal Microbiota in Newly Diagnosed Systemic Lupus Erythematosus Egyptian Patients
por: Gerges, Marian A., et al.
Publicado: (2021)

Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
por: Bruce, Ian N, et al.
Publicado: (2022)

Early cerebral volume reductions and their associations with reduced lupus disease activity in patients with newly-diagnosed systemic lupus erythematosus
por: Mak, Anselm, et al.
Publicado: (2016)

Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients
por: Silvagni, Ettore, et al.
Publicado: (2020)

A Survey on Sleep Disorders and Related Hormones in Patients with Newly Diagnosed Systemic Lupus Erythematosus
por: Sahebari, Maryam, et al.
Publicado: (2021)

Factors associated with choice of intensification treatment for type 2 diabetes after metformin monotherapy: a cohort study in UK primary care
por: Wilkinson, Samantha, et al.
Publicado: (2018)

Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: A retrospective analysis of US health insurance claims data
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study
por: Isaacs, John D, et al.
Publicado: (2019)

Comparative effects of sulphonylureas, dipeptidyl peptidase‐4 inhibitors and sodium‐glucose co‐transporter‐2 inhibitors added to metformin monotherapy: a propensity‐score matched cohort study in UK primary care
por: Wilkinson, Samantha, et al.
Publicado: (2020)

Cluster analysis of longitudinal treatment patterns in patients newly diagnosed with systemic lupus erythematosus in the United States
por: Kan, Hong, et al.
Publicado: (2014)

Increased Macroautophagy in Interferon-Gamma-Producing T Cells from Patients with Newly Diagnosed Systemic Lupus Erythematosus
por: Luo, Xiong-Yan, et al.
Publicado: (2018)

Cytokines in systemic lupus erythematosus, London, UK
por: Rahman, Anisur
Publicado: (2003)

Cost–consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK
por: Wright, Antony, et al.
Publicado: (2022)

Assessing the expression of immunosuppressive cytokines in the newly diagnosed systemic lupus Erythematosus patients: a focus on B cells
por: Abbasifard, Mitra, et al.
Publicado: (2020)

Nemaline myopathy in newly diagnosed systemic lupus erythematosus and Sjögren’s overlap syndrome complicated by macrophage activation syndrome
por: Vogel, Christina, et al.
Publicado: (2022)

Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
por: Langham, Sue, et al.
Publicado: (2019)

MRI for premature neonatal brain injury: a case report
por: Langham, Alexander
Publicado: (2017)

The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness
por: Gracia-Tello, Borja, et al.
Publicado: (2017)

Addressing Limitations and Enhancing Understanding: Feedback on ‘Major Infections of Newly Diagnosed Childhood-Onset Systemic Lupus Erythematosus’ [Letter]
por: Shuja, Muhammad Hamza
Publicado: (2023)

Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink
por: Douglas, Ian J, et al.
Publicado: (2013)

The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012
por: Rees, Frances, et al.
Publicado: (2016)

Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study
por: Floris, Alberto, et al.
Publicado: (2022)

Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series
por: Keyes, Emily, et al.
Publicado: (2021)

A systematic review comparing the evidence for kidney function outcomes between oral antidiabetic drugs for type 2 diabetes
por: Wilkinson, Samantha V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_demq2q3f6ihr1s5l5u64dsni5c